Based on its structural characteristics and prominent role in apoptosis, ILP-2 could be a new target for tumor therapy, suitable for molecular antagonists, vaccination strategies, small molecule inhibitors and gene therapy. This evidence concerns the gene BIRC8 and neoplasm.